drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy


































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   
































































































































































































































































Week of Mon, Oct 24th, 2011

ShelfX debuts in-aisle checkout, inventory management system

Start-up ShelfX has launched a wireless checkout and inventory management system for retailers that it said enables customers to shop without cashiers.

Mylan ships generic version of MS Contin

Mylan Inc. is launching morphine sulfate extended-release tablets, an opioid analgesic for the treatment of moderate to severe pain.

In Canada, FluMist named preferred flu vaccine for kids

Canada's National Advisory Committee on Immunization (NACI) has designated FluMist, AstraZeneca's nasal spray flu vaccine, as the preferred flu vaccination for children ages 2 to 17 without chronic health conditions.

Abbott launches Glucerna Hunger Smart for diabetics

Abbott has introduced Glucerna Hunger Smart nutrition shakes and nutrition bars for people with diabetes.

Help Remedies expands distribution to Walgreens

Help Remedies, a maker of "minimalist" over-the-counter medicines, is hitting the shelves at Walgreens.

Teva, Dr. Reddy's introduce Zyprexa generic

Teva Pharmaceutical Industries Ltd. and Dr. Reddy’s Laboratories (NYSE: RDY) announced the commercial launch of olanzapine tablets, an antipsychotic medication.

Kao Brands plans to change its name

As of next year, Kao Brands Co. will go under a new company name: Kao USA Inc.

Sanofi names Genzyme chief executive

Sanofi has appointed David Meeker as chief executive officer of its biotechnology subsidiary Genzyme Corp.

Advertisement